Izindaba

I-NEW YORK, Juni 23, 2022 (GLOBE NEWSWIRE) - I-Reportlinker.com imemezela ukukhishwa kombiko "I-Global Intravenous Therapy kanye ne-Intravenous Access Market size, Share and Industry Trends Analysis Report, Outlook and Forecast by End User, Application, Type, Region , 2022-2028″ - https://www.reportlinker.com/p06283441/?utm_source=GNW Indlela eshesha kakhulu yokufaka uketshezi ezingxenyeni ezihlukene zomzimba iwukwelashwa nge-IV.Isifo senhliziyo, unhlangothi, kanye nobuthi konke kwelashwa ngalo muthi.Kulokhu , isiguli kufanele selashwe ngomuthi ngokushesha ngangokunokwenzeka, ngaleyo ndlela sinikeze umuthi ngomthambo.Imithi yokwelapha ngamakhemikhali, ama-antibiotic, ama-antifungal, amaphilisi ezinhlungu, i-immune globulin zokwelapha, kanye nemithi yomfutho wegazi inikezwa ngomthambo.Ukwelashwa nge-intravenous (IV) kuyindlela yokulethwa kwemithi noketshezi emzimbeni ngomthambo.Imithi equkethe amavithamini namaminerali inikezwa nge-drip efakwe emithanjeni noma ngomjovo, okuvumela ukwelashwa kugeleze ngokushesha. Ngokulandela Ububanzi, ukuphathwa kwe-IV yilapho isiguli sisebenzisa ishubhu elibizwa ngokuthi i-cannula ukufaka izinto ngqo emithanjeni. Lokhu kungaba umphumela ongaseceleni. yomuthi noma ukuntuleka kokudla okunomsoco.Ukwelashwa kwe-IV kuyindlela evamile yokuhlinzeka ngoketshezi, izidakamizwa, ukwelashwa ngamakhemikhali, kanye nokumpontshelwa igazi ezigulini eziphelelwe amanzi emzimbeni.Phakathi nokuphathwa kwe-IV, imishini ehlukahlukene ye-IV efana ne-IV catheter, amaphampu okufakwayo, amathuluzi okuvimbela amandla, kanye nezinsiza zokuphatha. ziyasetshenziswa.IV ukulawulwa kokwelapha kuyashesha, kulula ukulandela, futhi akunayo imiphumela emibi yesisu.Kukhuthaza ukusabela ngokushesha kwamasosha omzimba futhi kuqede izifo ezingelapheki kunokwelashwa ngomlomo. iphampu yokufaka elawula inani lamakhemikhali okumele ahlinzekwe emzimbeni futhi angaqashelwa kalula.Imakethe yomhlaba wonke yokwelapha ngemithambo kanye nemishini yokufinyelela ngomthambo ilindeleke ukuba ikhule phakathi nesikhathi sokubikezela.Ukusabalala kwesifo sikashukela, ukwanda kwezigameko zezingozi zomgwaqo, kanye nokwanda kwezinqubo zokuhlinza kulindeleke ukuthi kuqhubekisele phambili imboni. Imboni iphinde igqugquzelwe ukukhula kwesidingo sezindlela eziyinkimbinkimbi, njengomuthi ongenanaliti. delivery.I-COVID-19 Impact COVID-19 inomthelela omuhle jikelele emakethe yokwelapha ye-IV. Ezigulini ezine-COVID-19 ehlobene ne-acute breathing distress syndrome, kunikezwa ukwelashwa kwe-IV (ARDS). Isibonelo, ukusetshenziswa kwe-immune immune I-globulin yokwelapha i-COVID-19 ARDS njenge-adjuvant ekhangayo ekwelapheni ama-ARDS ahlobene ne-COVID-19 ashicilelwe ku-Lancet Respiratory. Umuthi ngoNovemba 11, 2021 ngenxa yokuthi Ikhono lokushintsha amasosha omzimba amaningi ngasikhathi sinye.Ngakho-ke, ngokwenyuka kwenani leziguli ezine-ARDS ehlobene ne-COVID-19, isidingo sokwelashwa nge-IV kanye nemikhiqizo yokufinyelela ngomthambo siyakhula.Izici Zokukhula Kwemakethe Ezikhulayo kanye Nokwanda Kwabantu Abakhulakhulile Ukudlondlobala kwezifo ezihlukahlukene ezingelapheki ezidinga ukwelashwa kokufinyelela emithanjeni kuye kwanda kule minyaka eyishumi edlule. izifo ezinjengomdlavuza, ukwehluleka kwezinso nesifo senhliziyo, kanye nezindlela ezihlukahlukene zokuphila ezifana nomfutho wegazi ophakeme, isifo sikashukela, ukukhuluphala ngokweqile nokucindezeleka, zidinga ukunakekelwa okujulile ngesikhathi sokulaliswa esibhedlela.Eminyakeni embalwa ezayo, ukwanda komthwalo wezifo ezingamahlalakhona njengenhliziyo nemithambo yegazi. isifo, umdlavuza, isifo sohlangothi, nesifo sikashukela, kuhambisana nokuguga kwabantu, kuzokwandisa isidingo sokwelashwa ngomthambo.Intuthuko Yezobuchwepheshe Ama-catheter angena emthanjeni (i-peripheral kanye nemaphakathi), izesekeli ezinemishini yokuphepha, kanye amaphampu okufakwa ithiphu aphakathi kwezinsiza zobuchwepheshe ezifaka isandla ekwenzeni okuphephile, kwekhwalithi ephezulu ye-intravenous therapy (IVT).Njengoba ubuchwepheshe bezempilo buyisiyalo esiyinkimbinkimbi, esicatshangelwa futhi sixoxisana nsuku zonke ngochwepheshe bezempilo abathintekayo ekunakekelweni kwesiguli ekunakekelweni okukhulu. iyunithi, umkhakha wokunakekela ube nezinguquko eziphawulekayo ngenxa yokufakwa kobuchwepheshe obusha, futhi amaphampu okumnika asezingeni eliphezulu angenye yezinsiza zobuchwepheshe zokusiza ukuthola ukwelashwa okuphephile nokuphakeme kwekhwalithi ephezulu. (IVT) ukuzijwayeza.Izingqinamba Zemakethe Ukukhiqiza amaphampu kudinga imithetho eqinile kanye nokukhathazeka mayelana nezinkinga. Inqubo yokunikeza amalayisense amaphrojekthi amasha iqhutshwa ngokuphathelene nokukhiqizwa nokuqiniswa kwephampu. Ngaphezu kwalokho, ukukhuphuka kokubuyiselwa komkhiqizo ngenxa yokukhubazeka kokukhiqiza kuzobambezela ukwamukelwa kwalezi zindlela zokwelapha.Ngokwesibonelo, uFresenius Kabi ukhumbula i-Vigilant Agilia Drug Depot kanye neVolumat MC Agilia Infusion Pump in. Agasti 2019 ngenxa yezinkinga zesexwayiso ngokufakwa, okubaluleke kancane i-Keep Vein Open (KVO) nokunye i-software bugs.Isithiyo esikhulu ekukhuleni kwemboni izinkinga ezihambisana nokusetshenziswa kwezindlela ze-IV kanye nemikhiqizo yokufakwa kwe-IV.I-End User Outlook Ngokusekelwe kumsebenzisi wokugcina, imakethe ihlukaniswe yaba izibhedlela, izikhungo zokuhlinza ezimotweni, kanye nemitholampilo. ingxenye yesibhedlela izothatha isabelo esikhulu semali engenayo emakethe yokwelashwa nge-intravenous (IV) kanye nokufinyelela kwe-venous ngo-2021. Lokhu kungenxa yokwanda kwenani lokuhlinzwa okwenziwa uma kuqhathaniswa. ezikhungweni zokuhlinza ama-ambulensi kanye nemitholampilo.Ngaphezu kwalokho, ukukhula kwengxenye kwabangelwa ukwanda kokusetshenziswa kwe-intravenous therapy ezibhedlela, okuhlanganisa i-intravenous antibiotic therapy, izidakamizwa zeziguli ze-comatose, izidakamizwa ezingenakuphuzwa ngomlomo, i-radiology yokungenelela, izidakamizwa ezilwa nomdlavuza. , i-hemodialysis, ukuphinda amamephu esampula yegazi, kanye nokumpontshelwa igazi .Imakethe yokwelashwa kwe-IV kanye nemishini yokufinyelela emithanjeni iyakhula ngenxa yobuchwepheshe. intuthuko kanye nokutshalwa kwezimali ezibhedlela.I-Opplication Outlook Ngokusekelwe kuhlelo lokusebenza, imakethe ihlukaniswe yaba ukuphathwa kwezidakamizwa, imikhiqizo esekelwe egazini, izixazululo zokudla okunomsoco kanye ne-buffer, nemikhumbi yokwandisa.Ngo-2021, ingxenye ye-Volume Expander izothola isabelo semali esibalulekile emthanjeni. (IV) ukwelashwa kanye nemakethe yokufinyelela kwe-venous.Uketshezi olungena emthanjeni kungase kube usizo enanini elincane labasubathi abangezwani noketshezi; kodwa-ke, lokhu kufanele kugcinelwe abasubathi bezinga eliphezulu abanomlando wezimpawu eziqinile ngaphansi kokuqapha okuhle.Abanye abasubathi bangase bazuze ngokusebenzisa i-expander.Uketshezi olufakwa emthanjeni kanye nezibophelelo ze-plasma akuvunyelwe emiqhudelwaneni elawulwa yi-WADA.Eningini labasubathi, Ukwelashwa okujwayelekile kwe-IV akuyona inketho engcono kakhulu.Uhlobo lwe-Outlook Ngokusekelwe ohlotsheni, imakethe ihlukaniswe ngama-catheter afakwa emthanjeni, amaphampu okufakwayo, Izinaliti ze-hypodermic, izimbobo ezifakelwayo, nezinye. Ngo-2021, ingxenye ye-catheter efakwa emthanjeni izothatha isabelo esikhulu semali engenayo emakethe ye-intravenous (IV) kanye nokufinyelela kwe-venous. futhi ngesikhathi sokudluliselwa kwegazi, imithi, nezinye izakhamzimba ezingxenyeni ezihlukahlukene zomzimba.Amapayipi afakwa emthanjeni amashubhu amancane afakwa emgodini womzimba. noma ilume.I-intravenous catheter iyi-catheter efakwa emthanjeni esetshenziselwa ukuletha izidakamizwa, uketshezi, noma ezinye izindlela zokwelapha ngokuqondile egazini.Imvamisa ifakwa emthanjeni osengalweni, nakuba ingafakwa entanyeni, esifubeni, noma. I-groin.I-intravenous catheter iza ngosayizi nangezinhlobo ezahlukene, kuya ngokusetshenziswa kwawo okuhlosiwe.I-Regional Outlook Ngokusekelwe esifundeni, imakethe ihlukaniswe eNyakatho Melika, I-Europe, Asia Pacific & Latin America, Middle East & Africa.Ngo-2021, iNyakatho Melika iyisifunda esihamba phambili ekwelapheni nge-intravenous (IV) kanye nemakethe yokufinyelela kwe-venous ngokubamba isabelo semakethe esiphezulu kakhulu semali engenayo. ekwenyukeni kwenani leziguli, ukwanda kwezigameko zezingozi zomgwaqo, ukukhula okuphezulu kwezigameko zokuhlukumezeka, kanye nokwenyuka kwezimali ezitshalwa yinhlangano ekuthuthukiseni izikhungo zezokwelapha ezingcono kanye nemisebenzi ye-R&D. Umbiko wocwaningo lwemakethe uhlanganisa ukuhlaziywa kwababambe iqhaza ababalulekile. zemakethe.Izinkampani ezinkulu ezifakwe ephrofayilini embikweni zihlanganisa i-B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc. ., Smiths Group PLC kanye ne-AngioDynamics, Inc. Sebenzisa Amasu e-Intravenous (IV) Therapy kanye ne-Intravenous Access Market March 2022: UFresenius Kabi usayine isivumelwano sokuthola iFresenius Kabi, inkampani yokunakekelwa kwezempilo emhlabeni wonke. Ukuthengwa, okuklanyelwe ukuhlanganisa amasistimu okufakwa athuthukisiwe e-Ivenix kuphothifoliyo kaFresenius Kabi yokujova ngomthambo kanye nemikhiqizo yokwelapha ngokufakwa, kuzoletha ingxube ebanzi yemikhiqizo ezibhedlela zase-US. .Disemba 2021: U-Baxter wenza ubambiswano nomhlinzeki wezobuchwepheshe bezokwelapha wase-US u-Hillrom.Ngalokhu kubambisana, lezi zinkampani ezimbili zihlose ukuhlanganisa amabhizinisi amabili amakhulu ezobuchwepheshe bezokwelapha ukuze kuzuzwe umbono owabiwe wokuguqula ukunakekelwa kwezempilo emhlabeni wonke kanye nokwenza ngcono ukunakekelwa kweziguli.May 2021: I-Smiths Medical yenza ubudlelwano nenkampani yobuchwepheshe bezokwelapha i-Ivenix.Ngalobu budlelwano, lezi zinkampani ezimbili zihlose ukunikeza ububanzi obubanzi bokufakwa. izixazululo zokuphatha.Ukwengeza, iSmiths Medical izohlinzeka ngokutshalwa kwezimali kwamasu ebudlelwaneni besikhathi eside obuklanyelwe ukuguqula ukuphathwa kokuxubana nokuthuthukisa impilo yesiguli, kuyilapho kuhlangatshezwana nezidingo zabahlinzeki bezempilo.April 2021: I-B. Braun Medical yethula uhlelo olusha, I-Peripheral Advantage, yokuthuthukisa ulwazi lweziguli ngokwelashwa nge-peripheral ngemithambo. izinto eziyinkimbinkimbi ezihlobene nokwelashwa kwe-peripheral IV.Julayi 2019: U-Baxter uthola imvume ye-US Food and Drug Administration (FDA) yokuthi I-Myxredlin.Ukugunyazwa kuvumela i-insulin esheshayo yokujova ngomthambo ezibhedlela nakwezinye izindawo zokunakekela abaguli kakhulu futhi ineshalofu elibanzi lezinsuku ezingama-30 noma izinyanga ezingama-24 ekamelweni lokushisa uma ifakwe esiqandisini ephaketheni lokuqala ukuze kuqinisekiswe ukuvikeleka ekukhanyeni.Imibiko: Ngumsebenzisi Wokugcina. • Izibhedlela • Izikhungo Zokuhlinza Iziguli • Imitholampilo Ngokufaka Isicelo • Ukuphathwa Kwemithi • Imikhiqizo Yegazi • Izakhamzimba Nezixazululo Zesivikelo • Ukusabalalisa Imikhumbi Ngohlobo • I-Intravenous Catheter • Amaphampu Okufakwayo • Izinaliti Ze-Hypodermic • Izimbobo Ezifakwayo • Okunye NgeJografi • INyakatho Melika o USo Canadao Mexico Yonke iNyakatho Melika • I-Europe Germany o UKo France Russia Spain Italy o Yonke indawo yase-Europe • Asia Pacific China o Japan India Korea Singapore Malaysia o Rest of Asia Pacific • LAMEAo Brazil Argentina UAE Saudi Arabia South Africa Nigeria LAMEA Rest Company Profile• B. Braun Melsungen AG • Medtronic PLC• Terumo Corporation• Fresenius SE & Co. KGaA• Cardinal Health, Inc.• Pfizer, Inc.• Teleflex, Inc.• Baxter International, Inc.• Smiths Group PLC• AngioDynamics, Inc. Ukunikezwa Okuyingqayizivele • I-Exhaustive Coverage • Iningi Amathebula Emakethe Abanzi Nedatha • Imodeli Esekelwe Okubhaliselwe Iyatholakala • Intengo Engcono Kakhulu Iqinisekisiwe • Iqinisekisiwe Ucwaningo Lwangemva Kokuthengisa Lusekelwa Ukwenziwa Ngokwezifiso okungu-10% Funda umbiko ogcwele mahhala: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker yisixazululo esiwine umklomelo socwaningo lwemakethe.I-Reportlinker ithola futhi ihlele idatha yakamuva yemboni ukuze uthole lonke ucwaningo lwemakethe oludingayo ngokushesha endaweni eyodwa.______________________________